Phibro Animal Health (PAHC) Payables (2013 - 2026)

Phibro Animal Health's Payables history runs 14 years deep, the most recent figure standing at $129.6 million for Q1 2026.

• On a quarterly basis, Payables fell 1.5% year-over-year to $129.6 million in Q1 2026; TTM through Mar 2026 was $129.6 million, a 1.5% decrease from a year earlier, with the FY2025 full-year figure at $138.2 million, up 61.51% from the prior year.
• Payables eased to $129.6 million in Q1 2026 per PAHC's latest filing, from $133.3 million in the prior quarter.
• Across five years, Payables topped out at $138.2 million in Q2 2025 and bottomed at $73.9 million in Q2 2023.
• The 5-year median for Payables is $88.4 million (2022), against an average of $99.1 million.
• Across the five-year window, Payables retreated 22.74% in 2023 and surged 61.51% in 2025, its largest moves.
• Year by year, Payables stood at $80.5 million in 2022, then gained by 7.36% to $86.4 million in 2023, then increased by 15.09% to $99.4 million in 2024, then jumped by 34.04% to $133.3 million in 2025, then dropped by 2.74% to $129.6 million in 2026.
• Per Business Quant, the three latest PAHC Payables figures stand at $129.6 million (Q1 2026), $133.3 million (Q4 2025), and $130.6 million (Q3 2025).